The landscape of dementia diagnosis has progressed considerably with the advent of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology yrs before signs arise. Though these technological developments depict extraordinary progress in knowing neurodegenerative conditions, they